Position in SCLX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$7
+$1 QoQ
Shares Held
1
-50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 72 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Planning Group LLC holds $2,902,104 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,637 | $923,688 | |
| 2 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 3 | ABBV |
AbbVie Inc.
|
1,687 | $424,516 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,033 | $389,740 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
883 | $111,558 | |
| 6 | PFE |
Pfizer Inc
|
4,546 | $109,467 | |
| 7 | AZN |
Astrazeneca PLC
|
477 | $90,448 | |
| 8 | AMGN |
Amgen Inc
|
219 | $79,304 |
All Filings in SCLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7 | 1 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6 | 1 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $12 | 1 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,830 | 93 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5 | 1 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4 | 1 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $17 | 42 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $38 | 42 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $81 | 42 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $66 | 42 | Shares | Sole | 2024-05-07 | |
| 2023-06-30 | $233 | 42 | Shares | Sole | 2023-08-15 | |
| No filing history on record for this holder in this stock. | ||||||